FEAF
TPEx

3710 連展投控

7.12 ▼ 0.22 (3.00%) Close · 2026-11-13 · TPEx
Ask about 3710
This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.

Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.

Your risk profile
Conclusion

Several watch-outs (4) and no clear strengths in the data reviewed.

Points to watch for a moderate profile: see the items marked above.

No model narrative: the model call failed. The structured analysis above is complete on its own.

Strengths

——

Watch-outs

! Revenue fell -5.2% in 2025; latest quarter Q3 2026: 24.5% year on year. source (Financials) →
! Return on equity -75.2% with a -10.1% net margin: weak profitability. source (Key Stats) →
! Liabilities are 82.5% of total assets (Q3 2026): a heavy debt load. source (Financials) →
! Free cash flow was negative in 2025: -421 NT$ million, so spending exceeded operating cash. source (Financials) →

What to check before deciding

?Is the revenue decline temporary or structural?
?What would lift profitability, and how soon?
?Can operating cash cover the debt if conditions tighten?
?What is the spending for, and when does it start paying back?

What the analysis found

! Growth Revenue fell -5.2% in 2025; latest quarter Q3 2026: 24.5% year on year. source →
! Profitability Return on equity -75.2% with a -10.1% net margin: weak profitability. source →
! Debt Liabilities are 82.5% of total assets (Q3 2026): a heavy debt load. source →
! Cash flow Free cash flow was negative in 2025: -421 NT$ million, so spending exceeded operating cash. source →
· Filings 2 verified alert(s); latest on 2026-11-12: 代重要子公司連展科技股份有限公司公告董事會決議 現金增資發行新股 source →
· Filings 4 filing(s) are held or rejected and wait for human review. source →